State Street’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.8M | Buy |
|
|||||
|
2025
Q2 | $16.4M | Buy |
|
|||||
|
2025
Q1 | $15.4M | Sell |
|
|||||
|
2024
Q4 | $18M | Buy |
|
|||||
|
2024
Q3 | $19.1M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Buy |
|
|||||
|
2024
Q1 | $8.65M | Buy |
|
|||||
|
2023
Q4 | $6.71M | Buy |
|
|||||
|
2023
Q3 | $6.43M | Buy |
|
|||||
|
2023
Q2 | $9.52M | Buy |
|
|||||
|
2023
Q1 | $206K | Sell |
|
|||||
|
2022
Q4 | $154K | Buy |
|
|||||
|
2022
Q3 | $48K | Hold |
|
|||||
|
2022
Q2 | $26K | Hold |
|
|||||
|
2022
Q1 | $40K | Hold |
|
|||||
|
2021
Q4 | $48K | Hold |
|
|||||
|
2021
Q3 | $86K | Hold |
|
|||||
|
2021
Q2 | $167K | Sell |
|
|||||
|
2021
Q1 | $933K | Buy |
|
|||||
|
2020
Q4 | $2.32M | Buy |
|
|||||
|
2020
Q3 | $1.3M | Buy |
|
|||||
|
2020
Q2 | $1.56M | Buy |
|